Multifaceted roles of t6A biogenesis in efficiency and fidelity of mitochondrial gene expression

Yong Zhang,Jing-Bo Zhou,Yue Yin,En-Duo Wang,Xiao-Long Zhou
DOI: https://doi.org/10.1093/nar/gkae013
IF: 14.9
2024-01-18
Nucleic Acids Research
Abstract:N 6-Threonylcarbamoyladenosine at A37 (t6A37) of ANN-decoding transfer RNAs (tRNAs) is a universal modification whose functions have been well documented in bacteria and lower eukaryotes; however, its role in organellar translation is not completely understood. In this study, we deleted the mitochondrial t6A37-modifying enzyme OSGEPL1 in HEK293T cells. OSGEPL1 is dispensable for cell viability. t6A37 hypomodification selectively stimulated N1-methyladenosine at A9 (m1A9) and N2-methylguanosine at G10 (m2G10) modifications and caused a substantial reduction in the aminoacylation of mitochondrial tRNAThr and tRNALys, resulting in impaired translation efficiency. Multiple types of amino acid misincorporation due to the misreading of near-cognate codons by t6A37-unmodified tRNAs were detected, indicating a triggered translational infidelity. Accordingly, the alterations in mitochondrial structure, function, and the activated mitochondrial unfolded protein response were observed. Mitochondrial function was efficiently restored by wild-type, but not by tRNA-binding-defective OSGEPL1. Lastly, in Osgepl1 deletion mice, disruption to mitochondrial translation was evident but resulted in no observable deficiency under physiological conditions in heart, which displays the highest Osgepl1 expression. Taken together, our data delineate the multifaceted roles of mitochondrial t6A37 modification in translation efficiency and quality control in mitochondria.
biochemistry & molecular biology
What problem does this paper attempt to address?
The paper primarily explores the role of N6-threonylcarbamoyladenosine (t6A) in human mitochondrial tRNA (specifically hmtRNA Thr and hmtRNA Lys) and its impact on the efficiency and fidelity of mitochondrial gene expression. The research team constructed a human embryonic kidney 293T (HEK293T) cell line lacking the mitochondrial t6A modification enzyme OSGEPL1 (referred to as OSGEPL1-KO) using CRISPR/Cas9 technology. The study found that low levels of t6A modification in these cells led to an increase in specific types of methylation modifications (such as N1-methyladenosine m1A9 and N2-methylguanosine m2G10) and selectively reduced the aminoacylation levels of hmtRNA Thr and hmtRNA Lys. This further resulted in infidelity during mitochondrial translation, manifested as near-cognate codons being misrecognized, thereby affecting mitochondrial function and morphology. Despite the significant defects in mitochondrial translation caused by the loss of OSGEPL1, no obvious defects were observed in the heart tissue function of Osgepl1 knockout mice under physiological conditions, suggesting that different species may respond differently to this conserved modification. In summary, the study reveals the importance of t6A modification on human mitochondrial tRNA in maintaining mitochondrial translation efficiency and quality control.